-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The inflammatory process in cancer degrades muscle protein by activating ubiquitin proteasome degradation and reducing muscle protein synthesis.
The inflammatory process in cancer degrades muscle protein by activating ubiquitin proteasome degradation and reducing muscle protein synthesis.
The researchers conducted a cross-sectional study that included a total of 123 hospitalized cancer patients receiving chemotherapy and/or surgery.
The ROC curve shows that the best cut-off point for predicting the risk of sarcopenia is NLR≥6.
This study confirmed that in hospitalized cancer patients, systemic inflammation measured by NLR can indirectly predict the risk of sarcopenia.
This study confirmed that in hospitalized cancer patients, systemic inflammation measured by NLR can indirectly predict the risk of sarcopenia.
Original source:
Thaís C.
High neutrophil to lymphocytes ratio is associated with sarcopenia risk in hospitalized cancer patients.
Leave a message here